One-Year Outcomes of the First 1000 Patients Implanted With the Medtronic Micra AV Leadless Pacing System in France: The AV-CESAR Cohort Study

Heart, Artery and Coronary DiseasesTherapy and Intervention

First Large Comprehensive Core-Laboratory Evaluation of Implantation Depth and Clinical Outcomes in TAVR: Final Global Results from the Optimize PRO Prospective Study

JACC Cardiovasc Interv

Dvir D, Jilaihawi HA, Fraser D, Rodes-Cabau J, Nazif T, Mittal S, Grubb KJ, Gada H, Teiger E, Lin L, Rovin JD, Khalil RF, Sultan I, Yudi MB, Gardner B, Lorenz D, Chetcuti S, Patel NC, Harvey J, Mahoney P, Talreja D, Trani C, Mylotte D, Schwartz B, Jafar Z, Van der Heyden J, Maffeo D, Yong G, Valle-Fernández RD, Wang J, Gooley R, Yeh YJ, Yakubov SJ

doi: 10.1016/j.jcin.2026.05.007

Heart Failure

One-Year Outcomes in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction Prescribed Quadruple Medical Therapy at Discharge

JAMA Cardiol

Greene SJ, Xu H, Chiswell K, Felker GM, Lewsey SC, Divanji PH, Goertz HP, Heitner SB, Shreay S, Pandey A, Yancy CW, Butler J, Fonarow GC

doi: 10.1001/jamacardio.2025.5339

Therapy and Intervention

One-Year Outcomes of Screen Failures for Transcatheter Tricuspid Valve Repair: Insights From the TriSelect Study

Circ Cardiovasc Interv

Rudolph F, Goncharov A, Narang A, Körber ML, Puthumana JJ, Malaisrie SC, Meng Z, Baldrigde A, Rudolph TK, Friedrichs KP, Pfister R, Thomas JD, Potratz M, Rudolph V, Davidson CJ, Gerçek M

doi: 10.1161/CIRCINTERVENTIONS.125.016124

Myocardial Infarction

Drivers of 1-year mortality decline after acute myocardial infarction in England and Wales: a 15-year national cohort study

Heart

Ayayo SA, Martin GP, Zghebi S, Taxiarchi VP, Rashid M, Kontopantelis E, Mamas MA

doi: 10.1136/heartjnl-2024-325474

Hypertension

Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies)

Drugs Real World Outcomes

Escribano Subias P, Chakinala MM, Chin KM, Didden EM, Doad G, Farber HW, Gaine S, Hemnes AR, Highland KB, Lange TJ, McLaughlin V, Muller A, Rahman M, Remeňová T, Söderberg S, Venkatesh A, Kim NH

doi: 10.1007/s40801-025-00536-4

Myocardial Infarction

Outcomes after a first acute myocardial infarction in patients with or without congenital heart disease

Eur Heart J

Holmgren L, von Koch S, Andell P, Sörensson P, Christersson C, Trzebiatowska-Krzynska A, Fedchenko M, Mandelanakis Z, Johansson B, Mohammad MA, Hlebowicz J

doi: 10.1093/eurheartj/ehag216

COMMENTED

Cardiovascular Risk and Diseases

Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study

★ 2 Recommended and commented by Prof. emer. Dr Ulrich Keller, Faculty Member

Lancet Diabetes Endocrinol

Vazquez Arreola E, Gong Q, Hanson RL, Wang J, Sandforth L, He S, Sandforth A, Qian X, Giacca M, Bornstein SR, Fritsche A, Stefan N, Preissl H, Gregg EW, Marx N, Jumpertz-von Schwartzenberg R, Li G, Birkenfeld AL

doi: 10.1016/S2213-8587(25)00295-5

Atrial Fibrillation

Atrial fibrillation recurrence and outcomes in patients with hypertrophic cardiomyopathy: Insights from a nationwide real-world cohort

Heart Rhythm

Aglan A, Fath AR, Silver JS, Harnish P, Hook B, Maron MS, Rowin EJ

doi: 10.1016/j.hrthm.2026.03.1906